IT1131856B - Composizione farmaceutica per il trattamento di intossicazioni alcooliche - Google Patents

Composizione farmaceutica per il trattamento di intossicazioni alcooliche

Info

Publication number
IT1131856B
IT1131856B IT23103/80A IT2310380A IT1131856B IT 1131856 B IT1131856 B IT 1131856B IT 23103/80 A IT23103/80 A IT 23103/80A IT 2310380 A IT2310380 A IT 2310380A IT 1131856 B IT1131856 B IT 1131856B
Authority
IT
Italy
Prior art keywords
intoxications
alcoholic
treatment
pharmaceutical composition
pharmaceutical
Prior art date
Application number
IT23103/80A
Other languages
English (en)
Other versions
IT8023103A0 (it
Inventor
Massimo Baldacci
Original Assignee
Baldacci Lab Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baldacci Lab Spa filed Critical Baldacci Lab Spa
Priority to IT23103/80A priority Critical patent/IT1131856B/it
Publication of IT8023103A0 publication Critical patent/IT8023103A0/it
Priority to US06/214,033 priority patent/US4313952A/en
Priority to FR8111006A priority patent/FR2485372B1/fr
Priority to AU72349/81A priority patent/AU544780B2/en
Priority to PT7328781A priority patent/PT73287B/pt
Application granted granted Critical
Publication of IT1131856B publication Critical patent/IT1131856B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62Oxygen or sulfur atoms
    • C07D213/63One oxygen atom
    • C07D213/65One oxygen atom attached in position 3 or 5
    • C07D213/66One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal
    • C07D213/672-Methyl-3-hydroxy-4,5-bis(hydroxy-methyl)pyridine, i.e. pyridoxine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • C07D213/20Quaternary compounds thereof
IT23103/80A 1980-06-30 1980-06-30 Composizione farmaceutica per il trattamento di intossicazioni alcooliche IT1131856B (it)

Priority Applications (5)

Application Number Priority Date Filing Date Title
IT23103/80A IT1131856B (it) 1980-06-30 1980-06-30 Composizione farmaceutica per il trattamento di intossicazioni alcooliche
US06/214,033 US4313952A (en) 1980-06-30 1980-12-08 Method of treating acute alcoholic intoxication with pyridoxine P.C.A.
FR8111006A FR2485372B1 (fr) 1980-06-30 1981-06-03 Composition pharmaceutique pour le traitement des etats d'intoxication alcoolique aigue a base de 5-oxo-2-pyrrolidone carboxylate de pyridoxine et procede de preparation de ce dernier
AU72349/81A AU544780B2 (en) 1980-06-30 1981-06-29 Composition for treatment of alcoholic intoxication
PT7328781A PT73287B (en) 1980-06-30 1981-06-29 Pharmaceutical composition for the treatment of alcoholic intoxication containing pyridoxine-5-oxo-2-pyrrolidon-carboxylate and process for the preparation of the active compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT23103/80A IT1131856B (it) 1980-06-30 1980-06-30 Composizione farmaceutica per il trattamento di intossicazioni alcooliche

Publications (2)

Publication Number Publication Date
IT8023103A0 IT8023103A0 (it) 1980-06-30
IT1131856B true IT1131856B (it) 1986-06-25

Family

ID=11203809

Family Applications (1)

Application Number Title Priority Date Filing Date
IT23103/80A IT1131856B (it) 1980-06-30 1980-06-30 Composizione farmaceutica per il trattamento di intossicazioni alcooliche

Country Status (2)

Country Link
US (1) US4313952A (it)
IT (1) IT1131856B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4528295A (en) * 1983-08-15 1985-07-09 Boris Tabakoff Composition and method for reducing blood acetaldehyde levels
IT1263956B (it) * 1993-02-23 1996-09-05 Procedimento per la preparazione di 5-oxo-2-pirrolidoncarbossilato di piridossina
IL187159A0 (en) 2007-07-03 2009-02-11 Gur Megiddo Use of metadoxine in relief of alcohol intoxication
WO2010013242A1 (en) 2008-07-29 2010-02-04 Alcobra Ltd. Substituted pyridoxine-lactam carboxylate salts
IT1393338B1 (it) * 2009-03-06 2012-04-20 Baldacci Lab Spa Uso terapeutico della metadoxina come inibitore della fibrosi epatica.
EP2445498A1 (en) 2009-06-25 2012-05-02 Alcobra Ltd. A method for the treatment, alleviation of symptoms of, relieving, improving and preventing a cognitive disease, disorder or condition
US20150073023A1 (en) 2013-09-09 2015-03-12 Alcobra Ltd. Method Of Treating Fragile X Syndrome And Related Disorders
TW201605443A (zh) 2013-09-09 2016-02-16 亞克柏拉有限公司 治療x染色體脆折症及相關病症的方法
CN105906559B (zh) * 2016-06-14 2018-08-14 成都倍特药业有限公司 一种药用级美他多辛的一步合成法

Also Published As

Publication number Publication date
US4313952A (en) 1982-02-02
IT8023103A0 (it) 1980-06-30

Similar Documents

Publication Publication Date Title
IT8149407A0 (it) Derivato di amminoalchilfurano procedimento per produrlo e composizione farmaceutica che lo contiene
FI811745L (fi) Farmaceutisk komposition och foerfarande foer framstaellning daerav
IT8149325A0 (it) Procedimento per il trattamento dimateriali di rifiuto
FI822683A0 (fi) Inert fyllnadsmaterial foer farmaceutiska kompositioner
IT1162879B (it) Composizioni farmaceutiche
IT1194748B (it) Composizioni farmaceutiche per il trattamento di osteopatie
SE8300912D0 (sv) Kompositioner for behandling av glaukom
DK390182A (da) Fremgangsmaade til behandling af slutprodukter fra roeggasafsvovling
IT1198434B (it) Composizione farmaceutica comprendente gamma butirrobetaina per il trattamento di sindromi da carenze di carnitina
FI810056L (fi) Farmaceutiska foereningar
IT1131856B (it) Composizione farmaceutica per il trattamento di intossicazioni alcooliche
IT7950138A0 (it) Composizione farmaceutica per il trattamento dei parkinsonismi
IS2721A7 (is) Aðferð til framleiðslu lyfjasamsetninga til húðlækninga
IT8148952A0 (it) Amminoglucosidi ammidinati procedimento per loro preparazione e loro impiego come medicamenti
IT1210935B (it) Composizione farmaceutica per il trattamento di malattie cardiovascolari.
SE8300913D0 (sv) Kompositioner for behandling av glaukom
IT1159815B (it) Composizione medicinale per il trattamento di certe neurovirosi
IS2626A7 (is) Aðferð til framleiðslu á lyfjablöndum
IT8123052A0 (it) Procedimento per la preparazione di trattamento di pozzi.
IT8249072A0 (it) Composizioni farmaceutiche
IT1194116B (it) Procedimento per la preparazione di 2-amminoetanoli
IT1131855B (it) Procedimento per la preparazione di pirrolidon carbossilato di piridossina
IT8068350A0 (it) Composizione farmaceutica per il trattamento di malattie microvasco lari
FI831893A0 (fi) Foerfarande foer framstaellning av en farmaceutisk vattenhaltig komposition
IT8049902A0 (it) Composizione farmaceutica

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970627